Sep 102017

By Rebecca Harcourt, PhD

What’s your story, morning glory? Scientists use CRISPR technology to change flower colour in an ornamental plant

In a world-first, Japanese scientists have used the revolutionary CRISPR, or CRISPR/Cas9, genome- editing tool to change flower colour in an ornamental plant. Researchers from the University of Tsukuba, the National Agriculture and Food Research Organization (NARO) and Yokohama City University, Japan, altered the flower colour of the traditional Japanese garden plant, Japanese morning glory (Ipomoea nil or Pharbitis nil), from violet to white, by disrupting a single gene. This research highlights the huge potential of the CRISPR/Cas9 system to the study and manipulation of genes in horticultural plants.

Japanese morning glory, or Asagao, was chosen for this study as it is one of two traditional horticultural model plants in the National BioResource Project in Japan (NBRP). Extensive genetic studies of this plant have already been performed, its genome sequenced and DNA transfer methods established. In addition, as public concern with genetic technologies such as CRISPR/Cas9 is currently a social issue in Japan, studies using this popular and widely-grown plant may help to educate the public on this topic.

The research team targeted a single gene, dihydroflavonol-4-reductase-B (DFR-B), encoding an anthocyanin biosynthesis enzyme, that is responsible for the colour of the plant’s stems, leaves and flowers. Two other, very closely related genes (DFR-A and DRF-C) sit side-by-side, next to DFR-B. Therefore, the challenge was to specifically and accurately enzyme DFR-B gene without altering the other genes. The CRISPR/Cas9 system was used as it is currently the most precise method of gene editing.

The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 system is based on a bacterial defense mechanism. It is composed of two molecules that alter the DNA sequence. Cas9, an enzyme, cuts the two strands of DNA in a precise location so that DNA can be added or removed. Cas9 is guided to the correct location by gRNA, or guide RNA, a small piece of RNA that has been designed to be complementary to the target DNA sequence. Cas9 cuts the two strands of DNA at the target location, allowing DNA to be removed and/or added.

As reported on 30 August 2017 in Scientific Reports, a short DNA sequence in the Japanese morning glory DFR-B gene was selected as the target for the CRISPR/Cas9 system. This sequence contains the active site of the enzyme produced by the DFR-B gene. Disruption of this sequence should therefore de-activate the enzyme, resulting in an absence of the colour pigment, anthocyanin. The CRISPR/Cas9 system was inserted into tissue-cultured embryos of Japanese morning glory plants using the DNA-transferring capabilities of the plant bacterium Rhizobium. As expected, the DFR-B enzyme was successfully inactivated, resulting in approximately 75%of the transgenic plants with green stems and white flowers. Non-transformed plants with an active enzyme had violet stems and flowers. These changes in stem colour were observed very early in the tissue culture process. A series of genetic analyses confirmed that the DNA target sequence had been altered in the transgenic plants, with either DNA insertions or deletions in both copies of the DFR-B gene (so-called bi-allellic mutants). The other related genes, DFR-A and DFR-C, were examined and no mutations were found, confirming the high specificity of the CRISPR/Cas9 system.

Next, the researchers examined the inheritance of the CRISPR/Cas9-induced mutations by analyzing plants from the next generation. These plants looked exactly like their parents. Among these plants were some without any sign of the introduced DNA. This raises some interesting questions in terms of the regulation of genetically modified organisms (GMOs), as these next-generation plants are considered transgenic, based on process-based definitions (how they were made), and non- transgenic, based on product-based definitions (the presence of foreign DNA in the final product).

This technology is also extremely useful in confirming the function of genes. Experiments in the 1930s and 1990s used ‘forward’ genetic screening techniques to find the genes responsible for flower colour production in the Japanese morning glory. The CRISPR/Cas9 system described here is the ‘reverse’ genetic approach, used to find out what an organism looks like after a known gene is disrupted, and confirms that the DFR-B gene is the main gene responsible for colour in Japanese morning glory plants.

Currently, CRISPR/Cas9 technology is not 100% efficient, that is, not all targeted plants will be transgenic. The mutation rate in this study, 75%, however, was relatively high. This is one of the reasons this research will greatly facilitate those interested in the modification of flower colours and shapes using the CRISPR/Cas9 system in ornamental flowers or vegetables.

The story of the Japanese morning glory started in the 8th century AD, with the introduction of wild blue-flowered plants into Japan from China. In 1631, the first white-flowered Japanese morning glory was painted in Japan. What took nature nearly 850 years to achieve has taken less than one using the CRISPR/Cas9 system, indicating both its power and its potential.

Learn more: What’s your story, morning glory? Scientists use CRISPR technology to change flower colour in an ornamental plant


The Latest on: CRISPR/Cas9
  • RNA gets CRISPR
    on September 15, 2017 at 3:42 pm

    Locana Inc. is circumventing both problems by targeting CRISPR-Cas9 to RNA, and is building a pipeline for treating RNA-driven diseases. The technology is based on work by interim CEO Gene Yeo and his colleagues at the University of California San Diego ... […]

  • New technologies combined to identify specific DNA defect underlying a type of cancer
    on September 15, 2017 at 6:02 am

    (Medical Xpress)—A team of researchers from the Netherlands and the U.K. has developed a technique for studying inherited types of cancers using two relatively new technologies—organoid development and CRISPR/Cas9. In their paper published in the ... […]

  • Doubts raised over validity of CRISPR-edited human embryo study
    on September 14, 2017 at 5:27 pm

    Last month, an international team reported using CRISPR/Cas9 gene-editing techniques to remove a common genetic mutation from human embryos that causes the heart condition hypertrophic cardiomyopathy. Now, experts in embryology and genetics are calling ... […]

  • Plant geneticists develop a new application of CRISPR to break yield barriers in crops
    on September 14, 2017 at 12:47 pm

    Using tomato as an example, they have mobilized CRISPR/Cas9 technology to rapidly generate variants of the plant that display a broad continuum of three separate, agriculturally important traits: fruit size, branching architecture and overall plant shape. […]

  • For the first time, scientists change flower colour using gene-editing tool CRISPR-Cas9
    on September 14, 2017 at 1:36 am

    The final product was white flower with green stem. In what can be termed as a breakthrough achievement, Japanese scientists have altered the colour of a flower by using gene-editing tool. The beautiful morning glory flower or Asagao which is found in ... […]

  • Beware of These 5 Popular Investment Narratives
    on September 13, 2017 at 6:01 am

    The demographic trends of today may be less inexorable than thought, as advances in CRISPR/Cas9 gene editing technology and immunotherapy for treating cancer could extend lives and improve late-in-life quality of life. Although CRISPR/Cas9 and immuno ... […]

  • Benson Hill Biosystems Launches Novel Genome Editing CRISPR 3.0 Technology
    on September 12, 2017 at 5:03 am

    Uncertainty around the intellectual property landscape and broad claims surrounding CRISPR/Cas9 – currently the most widely used genome editing technology – perpetuates a barrier to entry for innovators wishing to utilize genome editing for the ... […]

  • Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9
    on September 11, 2017 at 5:10 am

    DAVIS, Calif.--(EON: Enhanced Online News)--Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, announced today that it has signed a global licensing agreement with the Broad Institute of MIT and Harvard for research use of the ... […]

  • Intellia For The Long Haul
    on September 8, 2017 at 5:23 am

    Intellia is striving to use the CRISPR/Cas9 technology to create a new class of therapeutic products to permanently edit disease-associated genes in a single course of treatment. The company is developing a gene knockout program for Transthyretin ... […]

via Google News and Bing News

Other Interesting Posts

Leave a Reply

%d bloggers like this: